Waltham, Mass.-based Corindus Vascular Robotics Inc. said it received the U.S. Food and Drug Administration's 510(k) clearance for a robotic-assisted surgery platform.
The clearance marks the first robotic movement in the technIQ series for the CorPath GRX platform, which is used in heart surgeries.
The software automation feature, called Rotate on Retract, enables the operator to quickly navigate to a targeted area by automatically rotating the guidewire upon joystick retraction.
The FDA approved the device for procedures related to artery diseases.
